Skip to main navigation Skip to search Skip to main content

Treatment of prolonged tacrolimus toxicity using phenytoin in a haemodialysis patient

  • SUNY Buffalo
  • Erie County Medical Center

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

What is known and objective: Treatment of tacrolimus toxicity includes holding tacrolimus and supportive care. The objective is to describe considerations for pharmacologic induction of tacrolimus metabolism. Case description: A 52-year-old male with a failed renal transplant on chronic haemodialysis developed tacrolimus toxicity due to a drug-drug interaction with darunavir/ritonavir. Tacrolimus concentrations were >60 ng/mL for 10 days despite holding tacrolimus and darunavir/ritonavir. Development of encephalopathy prompted initiation of phenytoin to induce tacrolimus metabolism. Tacrolimus concentration was <2 ng/mL within 4 days and mental status normalized. What is new and conclusion: Phenytoin metabolic induction is a therapeutic option for prolonged tacrolimus toxicity.

Original languageEnglish
Pages (from-to)640-643
Number of pages4
JournalJournal of Clinical Pharmacy and Therapeutics
Volume44
Issue number4
DOIs
StatePublished - Aug 2019

Keywords

  • haemodialysis
  • phenytoin
  • tacrolimus
  • toxicity

Fingerprint

Dive into the research topics of 'Treatment of prolonged tacrolimus toxicity using phenytoin in a haemodialysis patient'. Together they form a unique fingerprint.

Cite this